Taken together, these data support the hypothesis that the high PLT-binding to T cells in chronically inflamed MPN may be impairing the CALR- and JAK2-specific immune responses, and thus allowing the disease to progress unrestrained. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.